ABO Genotyping
By combining targeted amplification with long-read sequencing, we deliver high-resolution genotyping of the ABO, FUT1, and FUT2 genes, definitively resolving complex discrepancies such as cis-AB and B(A) while accurately identifying null alleles. The result is truly precise and unambiguous genotyping (covering non-hotspot, phasing, and structural variations) of the ABO and Hh blood group systems.
Gene Coverage: ABO, FUT1, FUT2
Technology: Single molecule real-time (SMRT) sequencing, CCS reads
Platform: PacBio Revio and Vega system
Application Areas
Benifits
1. For the hospital/blood bank
Reduce labor costs and reagent costs
Faster turn around time
Better use of negative or rare blood units
Build a comprehensive donor database
2. For the patient
Better quality of life for transfused patients
Reduce hospital admission time before and after the transfusion
Extend the period between transfusions
Reduce adverse reaction
WeChat QR Code